Association between 276G/T adiponectin gene polymorphism and new-onset diabetes after kidney transplantation

Transplantation

Volumn 96, Issue 12, 2013, Pages 1059-1064

  Nicoletto, Bruna B ^a   Souza, Gabriela C ^a   Fonseca, Natasha K O ^a   Centenaro, Analaura ^a   Manfro, Roberto C ^a,b   Canani, Luís Henrique S ^a,b   Gonçalves, Luiz Felipe Santos ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Adiponectin; CCL5; Kidney transplantation; New onset diabetes after transplantation; Polymorphism

Indexed keywords

ADIPONECTIN; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; EVEROLIMUS; GLUCOSE; GUANINE; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID; PREDNISONE; RANTES; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TYROSINE;

ADIPONECTIN GENE; ADULT; AGE; ARTICLE; BODY MASS; BRAZIL; CASE CONTROL STUDY; CAUCASIAN; CCL5 GENE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DNA POLYMORPHISM; DRUG USE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES AFTER TRANSPLANTATION; ONSET AGE; PATHOGENESIS; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 84891631699     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a45283     Document Type: Article

References (45)

1. Garcia GG, Harden P, Chapman J. World Kidney Day Steering C. The global role of kidney transplantation. Transplantation 2012; 93: 337.
2. Haller M, Gutjahr G, Kramar R, et al. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant 2011; 26: 2988.
3. Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Transplantation 2003; 75: SS3.
4. Pham PT, Pham PM, Pham SV, et al. New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes 2011; 4: 175.
5. Israni AK, Snyder JJ, Skeans MA, et al. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant 2010; 10: 338.
6. Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178.
7. Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440.
8. Razeghi E, Heydarian P, Amerian M, et al. The risk factors for diabetes mellitus after kidney transplantation. Saudi J Kidney Dis Transpl 2010; 21: 1038.
9. Mora PF. New-onset diabetes after renal transplantation. J Investig Med 2010; 58: 755.
10. Yates CJ, Fourlanos S, Hjelmesaeth J, et al. New-onset diabetes after kidney transplantation: changes and challenges. Am J Transplant 2012; 12: 820.
11. Sarno G, Muscogiuri G, De Rosa P. New-onset diabetes after kidney transplantation: prevalence, risk factors, and management. Transplantation 2012; 93: 1189.
12. Ghisdal L, Van Laecke S, Abramowicz MJ, et al. New-onset diabetes after renal transplantation: risk assessment and management. Diabetes Care 2012; 35: 181.
13. Kim YG, Ihm CG, Lee TW, et al. Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation. Transplantation 2012; 93: 900.
14. Kang ES, Magkos F, Kim BS, et al. Variants of the adiponectin and adiponectin receptor-1 genes and posttransplantation diabetes mellitus in renal allograft recipients. J Clin Endocrinol Metab 2012; 97: E129.
15. Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol 2007; 2: 31.
16. Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr Pharm Des 2010; 16: 1896.
17. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930.
18. Cook JR, Semple RK. HypoadiponectinemiaVcause or consequence of human "insulin resistance"? J Clin Endocrinol Metab 2010; 95: 1544.
19. Bayes B, Granada ML, Pastor MC, et al. Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am J Transplant 2007; 7: 416.
20. Bayes B, Lauzurica R, Granada ML, et al. Adiponectin and risk of newonset diabetes mellitus after kidney transplantation. Transplantation 2004; 78: 26.
21. Jeong KH, Moon JY, Chung JH, et al. Significant associations between CCL5 gene polymorphisms and post-transplantational diabetes mellitus in Korean renal allograft recipients. Am J Nephrol 2010; 32: 356.
22. Rollins BJ. Chemokines. Blood 1997; 90: 909.
23. Appay V, Rowland-Jones SL. RANTES: A versatile and controversial chemokine. Trends Immunol 2001; 22: 83.
24. Levy JA. The unexpected pleiotropic activities of RANTES. J Immunol 2009; 182: 3945.
25. Corsi MM, Leone G, Fulgenzi A, et al. RANTES and MCP-1 chemokine plasma levels in chronic renal transplant dysfunction and chronic renal failure. Clin Biochem 1999; 32: 455.
26. Baer PC, Koziolek M, Fierlbeck W, et al. CC-chemokine RANTES is increased in serum and urine in the early post-transplantation period of human renal allograft recipients. Kidney Blood Press Res 2005; 28: 48.
27. Herder C, Haastert B, Müller-Scholze S, et al. Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 2005; 54: S11.
28. Herder C, Peltonen M, Koenig W, et al. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish diabetes prevention study. Diabetes 2006; 55: 2340.
29. Nomura S, Shouzu A, Omoto S, et al. Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 2000; 121: 437.
30. Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415.
31. Yu AR, Xin HW, Wu XC, et al. Adiponectin gene polymorphisms are associated with posttransplantation diabetes mellitus in chinese renal allograft recipients. Transplant Proc 2011; 43: 1607.
32. Numakura K, Satoh S, Tsuchiya N, et al. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation 2005; 80: 1419.
33. Huang MC, Wang TN, Lee KT, et al. Adiponectin gene SNP276 variants and central obesity confer risks for hyperglycemia in indigenous Taiwanese. Kaohsiung J Med Sci 2010; 26: 227.
34. Yang WS, Yang YC, Chen CL, et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr 2007; 86: 509.
35. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536.
36. Szopa M, Malczewska-Malec M, Wilk B, et al. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol 2009; 46: 317.
37. Katakami N, Kaneto H, Matsuoka TA, et al. Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes. Atherosclerosis 2012; 220: 437.
38. Sun K, Li Y, Wei C, et al. Recessive protective effect of ADIPOQ rs1501299 on cardiovascular diseases with type 2 diabetes: a metaanalysis. Mol Cell Endocrinol 2012; 349: 162.
39. Yu S, Ryu H, Park H, et al. Adiponectin gene SNP 276G Y9 T, nutrient intakes, and cardiovascular disease risk in Korean type 2 DM patients. Nutr Res Pract 2007; 1: 363.
40. Hwang JY, Park JE, Choi YJ, et al. SNP276G 9 T polymorphism in the adiponectin gene is associated with metabolic syndrome in patients with type II diabetes mellitus in Korea. Eur J Clin Nutr 2010; 64: 105.
41. Han LY,Wu QH, Jiao ML, et al. Associations between single-nucleotide polymorphisms (+45T9G, +276G9T,-11377C9G,-11391G9A) of adiponectin gene and type 2 diabetes mellitus: A systematic review and metaanalysis. Diabetologia 2011; 54: 2303.
42. Woo JG, Dolan LM, Deka R, et al. Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. Diabetes 2006; 55: 523.
43. Herder C, Illig T, Baumert J, et al. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984Y2002. Eur J Endocrinol 2008; 158: R1.
44. Böger CA, Fischereder M, Deinzer M, et al. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis 2005; 183: 121.
45. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35: S64.